Free Trial
NASDAQ:KIDS

OrthoPediatrics (KIDS) Stock Price, News & Analysis

OrthoPediatrics logo
$26.34 -0.13 (-0.49%)
(As of 11/22/2024 ET)

About OrthoPediatrics Stock (NASDAQ:KIDS)

Key Stats

Today's Range
$26.13
$26.81
50-Day Range
$22.69
$32.28
52-Week Range
$22.41
$36.23
Volume
87,002 shs
Average Volume
192,941 shs
Market Capitalization
$637.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$40.00
Consensus Rating
Moderate Buy

Company Overview

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Pediguard, Pediatric Nailing Platform | Femur, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIMTM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIROTM Growth Modulation System, PNP Tibia System, ApiFix Mid-C System, and Mitchell Ponseti. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.

OrthoPediatrics Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
81st Percentile Overall Score

KIDS MarketRank™: 

OrthoPediatrics scored higher than 81% of companies evaluated by MarketBeat, and ranked 215th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    OrthoPediatrics has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on 2 buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    OrthoPediatrics has only been the subject of 3 research reports in the past 90 days.

  • Read more about OrthoPediatrics' stock forecast and price target.
  • Earnings Growth

    Earnings for OrthoPediatrics are expected to grow in the coming year, from ($0.93) to ($0.86) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of OrthoPediatrics is -21.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of OrthoPediatrics is -21.41, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    OrthoPediatrics has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about OrthoPediatrics' valuation and earnings.
  • Percentage of Shares Shorted

    5.59% of the float of OrthoPediatrics has been sold short.
  • Short Interest Ratio / Days to Cover

    OrthoPediatrics has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in OrthoPediatrics has recently decreased by 1.69%, indicating that investor sentiment is improving.
  • Dividend Yield

    OrthoPediatrics does not currently pay a dividend.

  • Dividend Growth

    OrthoPediatrics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.59% of the float of OrthoPediatrics has been sold short.
  • Short Interest Ratio / Days to Cover

    OrthoPediatrics has a short interest ratio ("days to cover") of 5.7.
  • Change versus previous month

    Short interest in OrthoPediatrics has recently decreased by 1.69%, indicating that investor sentiment is improving.
  • News Sentiment

    OrthoPediatrics has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for OrthoPediatrics this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for KIDS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, OrthoPediatrics insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    31.80% of the stock of OrthoPediatrics is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    69.05% of the stock of OrthoPediatrics is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about OrthoPediatrics' insider trading history.
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Stock News Headlines

[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
OrthoPediatrics (NASDAQ:KIDS) Stock, Option Chain
See More Headlines

KIDS Stock Analysis - Frequently Asked Questions

OrthoPediatrics' stock was trading at $32.51 on January 1st, 2024. Since then, KIDS stock has decreased by 19.0% and is now trading at $26.34.
View the best growth stocks for 2024 here
.

OrthoPediatrics Corp. (NASDAQ:KIDS) announced its quarterly earnings data on Wednesday, November, 3rd. The company reported ($0.15) earnings per share for the quarter, beating analysts' consensus estimates of ($0.28) by $0.13. The firm earned $25.08 million during the quarter. OrthoPediatrics had a negative net margin of 15.00% and a negative trailing twelve-month return on equity of 5.78%.

OrthoPediatrics (KIDS) raised $52 million in an initial public offering (IPO) on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel acted as the underwriters for the IPO and William Blair and BTIG were co-managers.

Top institutional investors of OrthoPediatrics include Brown Capital Management LLC (9.26%), Wellington Management Group LLP (3.65%), Wasatch Advisors LP (1.95%) and State Street Corp (1.73%). Insiders that own company stock include David R Bailey, Mark C Throdahl, Fred Hite, Gregory A Odle, Daniel J Gerritzen, Joseph W Hauser, Terry D Schlotterback, Harold Ruf and Jennifer N Pritzker.
View institutional ownership trends
.

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that OrthoPediatrics investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

Last Earnings
11/03/2021
Today
11/22/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/05/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:KIDS
Employees
200
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$40.00
High Stock Price Target
$50.00
Low Stock Price Target
$28.00
Potential Upside/Downside
+51.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
3 Analysts

Profitability

Net Income
$-20,970,000.00
Pretax Margin
-17.09%

Debt

Sales & Book Value

Annual Sales
$189.67 million
Book Value
$15.32 per share

Miscellaneous

Free Float
16,515,000
Market Cap
$637.85 million
Optionable
Optionable
Beta
1.16
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

This page (NASDAQ:KIDS) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners